investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Cancer Immunology Research at Brigham Young University
Kim O'Neill
2 Collaborator(s)
Funding source
Brigham Young University
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Connor Peck
Brigham Young University
Provo, United States
Jake Lattin
Brigham Young University
Provo, United States
Kim O'Neill
Brigham Young University
Provo, United States
Related projects
Li Tang
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis
Breast
Susan E Erdman
GI Tract Dysbiosis and Breast Cancer
Breast
Mien-Chie Hung
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
Breast
Martin Brechbiel
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
Prostate
Ramesh K Ganju
Role of S100A7 in Breast Cancer Progression and Metastasis
Breast
Michael Karin
IKK <alpha> and the Control of Prostate Cancer Metastasis
Prostate
Pathology
Characterization of the Biological Activities of Novel Epigenetic Modulators
Trachea, bronchus and lung
Pathology
Thomas Sayers
Mechanisms of Immune-mediated Tumor Cell Destruction
Breast
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia